Wolters Kluwer Named Top Innovation Leader in Frost & Sullivan’s 2025 Clinical Decision Support Report

Wolters Kluwer Health has been recognized as a leading Clinical Decision Support System (CDSS) provider by Frost & Sullivan in its 2025 Frost Radar report. The company, which provides the popular UpToDate clinical decision support tool, ranks highest in innovation and is the sole recipient of the "Company to Action" designation among the 10 companies highlighted in the report. Located in Waltham, Massachusetts, Wolters Kluwer Health has consistently maintained its position as a market leader, also ranking highly in the 2023 Frost Radar evaluation. The report credits the company's substantial investment in research and development, along with its strategic integration of emerging technologies like generative artificial intelligence (Gen AI), for its continued success and innovation in the CDSS sector. One of the key factors contributing to Wolters Kluwer's leadership is the introduction of UpToDate Enterprise Edition. This platform aims to unify buyers, administrators, and care teams, thereby improving care delivery and maximizing return on investment. It offers advanced analytics that provide comprehensive insights into product usage, community trends, educational needs, and the broader impact of UpToDate on healthcare systems. Dr. Rishi Pathak, Global Director of Healthcare & Life Sciences at Frost & Sullivan, noted, “The Frost Radar delves deeply into the CDSS market and evaluates its players. Our analysis reveals that Wolters Kluwer has achieved significant growth by prioritizing innovation and customer-centric solutions. Their strategy to integrate UpToDate into the clinician workflow and extend its reach into operational and financial processes further solidifies their leadership position.” Wolters Kluwer Health has recently made strides in integrating UpToDate with various ambient AI platforms, such as Abridge, Suki, and Microsoft. These integrations enhance the functionality and usability of UpToDate, making it even more effective in supporting clinicians' decision-making processes. Greg Samios, CEO of Wolters Kluwer Health, stated, “Receiving the recognition as the innovation leader in the Frost Radar underscores our dedication to innovation and interconnectedness. It validates our commitment to revolutionizing healthcare through product innovation and strategic partnerships. We are committed to helping providers make quicker and more informed decisions throughout the care continuum, while also aiding organizations in optimizing their UpToDate investments through insightful analytics, consistent content, seamless integration, and AI-driven enhancements.” For more details, readers can refer to the Frost Radar report on CDSS available on Wolters Kluwer’s website or explore additional news and updates from the company. Wolters Kluwer (Euronext: WKL) is a multinational corporation that specializes in information, software solutions, and services for healthcare professionals, tax and accounting experts, financial and corporate compliance officers, legal and regulatory specialists, and corporate performance and ESG (Environmental, Social, and Governance) managers. With an annual revenue of €5.9 billion for the fiscal year 2024, the company serves clients in over 180 countries and operates in more than 40 nations, employing roughly 21,600 individuals worldwide. Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer is recognized for its deep domain expertise and cutting-edge technology, which it leverages to support critical daily decisions in various professional fields. To learn more about Wolters Kluwer and stay updated on its latest developments, visit their official website at www.wolterskluwer.com and connect with them on LinkedIn, Facebook, YouTube, and Instagram.